Illumina, Inc., is a leading developer, manufacturer and marketer of life science appliances and integrated systems for analyzing gene variation and gene function. The company was formed in California in April 1998 and reorganized in Delaware in July 2000. The company utilizes patented technology to provide a range of genetic analysis solutions as well as products and services for highly interconnected markets, including gene sequence, gene type, gene expression and molecular diagnostic markets. The company's customers include leading genomic research centers, academic institutions, government-administered laboratories, clinical research organizations, as well as pharmaceutical companies, biotechnology companies, agricultural product genome identification research and development companies and customer genome identification companies. 

Expected P&L on Expiry

Key Stats

Pricing Model

About ILMN20260918C190